Propiedad y actividad de insiders de 4D Molecular Therapeutics, Inc. (FDMT): operaciones de insiders, transacciones del Senado y la Cámara de EE. UU. y acciones en circulación. Sigue cómo operan la acción los directivos y los políticos.
Precio
| Precio | $13.76 |
| Capitalización | $719M |
| Bolsa | NASDAQ |
| País | US |
Operaciones Recientes de Insiders
| Fecha | Insider | Tipo | Acciones | Valor |
|---|---|---|---|---|
| 2026-09-14 | Kirn David | S-Sale | 58,333 | $811K |
| 2026-09-01 | Bizily Scott | M-Exempt | 584 | $4K |
| 2026-09-01 | Bizily Scott | S-Sale | 584 | $8K |
| 2026-09-01 | Bizily Scott | M-Exempt | 584 | $4K |
| 2026-08-19 | Kirn David | M-Exempt | 50,000 | $207K |
| 2026-08-19 | Kirn David | S-Sale | 43,149 | $663K |
| 2026-08-19 | Kirn David | S-Sale | 25,927 | $426K |
| 2026-08-19 | Kirn David | M-Exempt | 50,000 | $207K |
| 2026-08-13 | Bizily Scott | M-Exempt | 1,635 | $7K |
| 2026-08-17 | Bizily Scott | M-Exempt | 1,635 | $7K |
Balance (10 años)
| Año | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| Caja y Equivalentes | $23.9M | $91.8M | $49.7M | $276.7M | $153.0M | $52.4M | $249.1M | $149.3M | $60.2M |
| Inversiones a Corto | 0 | 0 | 0 | 0 | $94.8M | $161.2M | $39.1M | $275.5M | $342.4M |
| Cuentas por Cobrar | $321000 | $1.1M | $978000 | $1.5M | $47000 | 0 | 0 | 0 | 0 |
| Inventario | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Corrientes | $24.5M | $94.1M | $52.5M | $282.7M | $256.3M | $220.5M | $296.6M | $434.9M | $413.1M |
| Inmovilizado Material | $2.7M | $2.5M | $5.0M | $5.1M | $29.0M | $35.3M | $31.7M | $40.6M | $33.0M |
| Fondo de Comercio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Intangibles | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Totales | $27.3M | $97.0M | $58.2M | $288.3M | $353.5M | $261.8M | $339.9M | $560.4M | $566.7M |
| Cuentas por Pagar | $460000 | $954000 | $1.7M | $1.8M | $4.8M | $3.3M | $3.5M | $4.4M | $11.2M |
| Deuda a Corto | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Pasivos Corrientes | $5.9M | $8.1M | $13.0M | $16.7M | $16.3M | $15.7M | $19.0M | $29.1M | $44.0M |
| Deuda a Largo | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Pasivos Totales | $46.9M | $124.6M | $131.2M | $31.9M | $34.4M | $30.5M | $32.1M | $49.8M | $61.0M |
| Reservas | -$20.5M | -$30.0M | -$79.0M | -$135.7M | -$207.0M | -$314.5M | -$415.3M | -$576.2M | -$716.3M |
| Patrimonio Neto | -$19.6M | -$27.6M | -$73.0M | $256.4M | $319.1M | $231.3M | $307.8M | $510.6M | $505.7M |
| Deuda Total | 0 | 0 | 0 | 0 | $16.4M | $16.1M | $14.7M | $24.6M | $21.4M |
| Deuda Neta | -$23.9M | -$91.8M | -$49.7M | -$276.7M | -$231.3M | -$197.4M | -$273.6M | -$400.3M | -$381.2M |
| Capital Circulante | $18.6M | $86.0M | $39.6M | $265.9M | $239.9M | $204.8M | $277.6M | $405.8M | $369.1M |
Salud financiera
| Deuda / Patrimonio | 0.10 |
| Ratio corriente | 8.03 |
| Piotroski F-Score | 4 |
| Altman Z-Score | 2.50 |
Rentabilidad
| Rentabilidad sobre capital | -41.33% |
| Rentabilidad sobre capital invertido | -43.77% |
| Rentabilidad sobre activos | -36.37% |
| Margen bruto | 42.00% |
| Margen operativo | -214.24% |
| Margen neto | -194.74% |
Empresas relacionadas: ADCT · BCYC · CMPX · GOSS · KALV · LXRX · NMRA
Explorar sector: Healthcare · Biotechnology
Más secciones de FDMT: Resumen · Financieros · Valoración · Estadísticas · Estimaciones · Técnico · Noticias · Eventos
Descubre más: Radar — señales de acciones infravaloradas · Academia de Inversión — aprende a analizar acciones